no scripts enabled
Medikabazaar
Cart
Biovac A 0.5ml Vaccine 0.5ml Injection
Biovac A 0.5ml Vaccine 0.5ml Injection: Image 1
Biovac A 0.5ml Vaccine 0.5ml Injection: Image 2
Biovac A 0.5ml Vaccine 0.5ml Injection: Image 3

Your Advantages

Biovac A 0.5ml Vaccine 0.5ml Injection

₹1,232

₹2,210

44% Off

Exclusive of 5% GST

Pack Size

Variant unavailable, Please select another variant

Brand Wockhardt

Biovac A 0.5ml Vaccine is a live attenuated vaccine indicated for active immunization against Hepatitis A, a contagious liver infection caused by the hepatitis A virus (HAV). It is formulated from the H2 attenuated strain of the Hepatitis A virus, propagated in human diploid cells, to stimulate the body's immune system to produce protective antibodies.

This vaccine is suitable for adults and children aged 1 year and older seeking protection against Hepatitis A. It is administered as a single 0.5ml dose via subcutaneous injection, typically over the deltoid muscle of the upper arm.

Biovac A 0.5ml Vaccine requires cold-chain storage, maintaining a temperature between +2°C and +8°C, protected from light, and must not be frozen. The vaccine is supplied as a freeze-dried powder and requires reconstitution with 0.5ml sterile water for injection, which is provided with the vial, and should be used within 1 hour after reconstitution.



Key Features : 

Contains live attenuated Hepatitis A virus (H2 strain) for active immunization
Approved for use in adults and children aged 1 year and older
Requires cold-chain storage at +2°C to +8°C, protected from light, and must not be frozen
Administered via subcutaneous injection, typically in the deltoid muscle
A single 0.5ml dose is typically sufficient, with a booster dose usually not required
Requires reconstitution with 0.5ml sterile water for injection and should be used within 1 hour of reconstitution
Regulatory approval in India (implied by CDSCO documentation)

Biovac A Vaccine comprises a weakened hepatitis A virus (inactivated but immunogenic) suspended in a buffered saline solution, accompanied by stabilizers and trace amounts of preservatives to maintain potency.

Antigen CompositionHepatitis A Live attenuated vaccine > 6.5 Lg CCID50 (H2 attenuated strain of HAV cultured in human diploid cells)
Approved Indications and Target PopulationActive immunization against Hepatitis A in adults and children aged 1 year and older
Cold-chain Storage Temperature+2°C to +8°C, protect from light, do not freeze
Route of AdministrationSubcutaneous injection
Regulatory ApprovalApproved by regulatory authorities in India
Schedule / Dosing IntervalsSingle dose of 0.5ml; booster dose usually not required
Reconstitution RequirementsRequires reconstitution with 0.5ml sterile water for injection; use within 1 hour after reconstitution

This is an intramuscular injection (site of administration for this drug is muscle; most administered to deltoid muscle i.e. upper arm).

Step 1: Locate & Clean 2-inch area around the site with alcohol swab or pad.

Step 2: Prepare and plunge-in the drug into syringe from the vial.

Step 3: Insert the needle & plunge-out at a 90° angle to the skin with a quick thrust.

Step 4: Withdraw the needle at the same angle & press a cotton ball over site.

NOTE: Do not self-administer. It is intended to be used by healthcare professionals only.

  • Any allergic reactions or injection site discomfort should be reported immediately. 
  • It should only be taken under prescription. 
  • Avoid use if you have had previous severe immunological reactions.
  • Monitoring patients' post-administration is advisable to prevent risks.
  • Pregnant and breastfeeding mothers should avoid use.
  • Always store capsules in a cool, dry place away from direct light.

Overview of Biovac A Vaccine (0.5ml Injection)

Biovac A vaccine is a hepatitis A injection administered as a 0.5ml injection to provide protection against hepatitis A virus infection. It is recommended for children and adults at risk of exposure to hepatitis A, including travellers to endemic areas, healthcare workers, and individuals with chronic liver disease. The vaccine works by stimulating the immune system to produce antibodies, offering long-lasting immunity and helping prevent hepatitis A-related liver infections. Biovac A is typically given in a two-dose schedule, with the second dose administered 6–18 months after the first to ensure optimal protection.

 

Biovac A Vaccine Uses and Indications in Healthcare

Biovac A Vaccine uses is primarily to prevent hepatitis A infection in...

twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited